Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, central nervous system cancer, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 1 / Phase 22026-09-14NCT07243470

3 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1

Swipe the table sideways for more columns.